West Virginia · 2026 Regular Session
The purpose of this bill is to add crystalline polymorph psilocybin in the permitted list of distributed and prescribed drugs, if approved by the United States Food and Drug Administration and scheduled by the United States Drug Enforcement Administration.
On 1st reading, House Calendar (2026-02-02)